CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Barry Myers will be speaking on a panel discussing financing mechanisms for emerging companies at the Life Sciences Summit 2011 in New York on November 16.
News | 11. 11. 2011
